LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Carbohydrate doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9,11-O-methylene derivatives of 9-dihydroerythromycin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-[3&prim...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-(N'-substituted hydrazone) derivatives of erythromycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-.beta.-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-amino-14-membered macrolides derived from leucomycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-amino-3-keto erythromycin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-deoxo-9a-aza-11-deoxy-9a-homoerythromycin a 9a,11-cyclic carba

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-Desoxoerythromycin compounds as prokinetic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-ketospinosyn derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-N-ethenyl derivatives of 9(S)-erythromycylamine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9-R-azacyclic erythromycin antibiotics

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9.alpha.-Aza-9.alpha.-homoerythromycin compounds, pharmaceutical

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9.alpha.-Aza-9.alpha.-homoerythromycin compounds, pharmaceutical

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9A, 11-2C-bicyclic 9a-azalide derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9a, 11-3C-bicyclic 9a-azalide derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O-...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9a-azalides as veterinary antimicrobial agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9a-azalides with anti-inflammatory activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

9a-azalides with antibacterial activity